Updated from 8:48 a.m. EST
Abbott Laboratories (ABT) matched Wall Street's fourth-quarter earnings estimates Wednesday and reiterated its forecast for double-digit profit growth in 2009.
The diagnostics, medical devices and drug maker reported net income for the fourth quarter of $1.54 billion, or 98 cents a share, compared with net income of $1.2 billion, or 77 cents a share, in the year-ago quarter.
Excluding special items, Abbott reported a 14% increase in earnings per share to $1.06 in the fourth quarter, in line with the Street's consensus estimate.Fourth-quarter revenue rose 10% to $7.95 billion, essentially matching the consensus analyst forecast of $8 billion. Abbott reported revenue of $7.22 billion in the year-ago quarter. Abbott reiterated its 2009 earnings forecast, first offered Jan. 12, in the range of $3.65 to $3.70 a share on both a GAAP and adjusted basis. At the time, Wall Street was expecting earnings of $3.66 a share. The midpoint of Abbott's guidance represents 10% growth over 2008 adjusted earnings of $3.32 a share. Abbott's 2009 earnings outlook includes the company's planned $2.8 billion purchase of eye care company Advanced Medical Optics (EYE). The bullish forecast offered by Abbott management stands in contrast with diversified health care giant Johnson & Johnson (JNJ), which said Tuesday that this year's revenue would fall from the reported 2008 level, the company's first annual revenue decline in 75 years. Johnson & Johnson blamed the recession, which is forcing consumers to spend less on health care products, both prescription drugs and consumer products.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV